Journal article
Fluoroquinolone Use and Clostridium difficile–Associated Diarrhea
Emerging Infectious Diseases, Vol.9(6), pp.730-733
06/2003
DOI: 10.3201/eid0906.020385
PMCID: PMC3000134
PMID: 12781017
Abstract
We performed a case-control study to evaluate the association between antibiotic use and Clostridium difficile –associated diarrhea (CDAD), matching for admission unit and time at risk for CDAD. A multivariable regression model showed that treatment with fluoroquinolones (odds ratio 12.7; 95% confidence interval 2.6 to 61.6) was the strongest risk factor for CDAD.
Details
- Title: Subtitle
- Fluoroquinolone Use and Clostridium difficile–Associated Diarrhea
- Creators
- Margaret E McCusker - University of Maryland, Baltimore, Maryland, USAAnthony D Harris - Veterans Affairs Maryland Health Care System, Baltimore, Maryland, USAEli Perencevich - Veterans Affairs Maryland Health Care System, Baltimore, Maryland, USAMary-Claire Roghmann - Veterans Affairs Maryland Health Care System, Baltimore, Maryland, USA
- Resource Type
- Journal article
- Publication Details
- Emerging Infectious Diseases, Vol.9(6), pp.730-733
- DOI
- 10.3201/eid0906.020385
- PMID
- 12781017
- PMCID
- PMC3000134
- NLM abbreviation
- Emerg Infect Dis
- ISSN
- 1080-6040
- eISSN
- 1080-6059
- Publisher
- Centers for Disease Control and Prevention
- Language
- English
- Date published
- 06/2003
- Academic Unit
- Epidemiology; Internal Medicine
- Record Identifier
- 9983779496202771
Metrics
18 Record Views